Effects of human atrial natriuretic peptide on renal function in patients undergoing abdominal aortic aneurysm repair

Critical Care Medicine

Volumn 36, Issue 3, 2008, Pages 745-751

  Mitaka, Chieko ^a   Kudo, Toshifumi ^a   Jibiki, Masatoshi ^a   Sugano, Norihide ^a   Inoue, Yoshinori ^a   Makita, Koshi ^a   Imai, Takasuke ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Abdominal aortic aneurysm; Atrial natriuretic peptide; Brain natriuretic peptide; Ischemia reperfusion injury; Placebo controlled trial; Renal dysfunction

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ALPHA; BRAIN NATRIURETIC PEPTIDE; CREATININE; N ACETYL BETA GLUCOSAMINIDASE; PLACEBO; SODIUM;

ABDOMINAL AORTA ANEURYSM; AGED; ANEURYSM SURGERY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG DOSE INCREASE; DRUG RESPONSE; FEMALE; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LOW DRUG DOSE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINE VOLUME; DRUG EFFECT; KIDNEY; PHYSIOLOGY; PROSPECTIVE STUDY;

AGED; AORTIC ANEURYSM, ABDOMINAL; ATRIAL NATRIURETIC FACTOR; FEMALE; HUMANS; KIDNEY; MALE; PROSPECTIVE STUDIES;

EID: 44449168774     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0B013E3181659118     Document Type: Article

References (42)

1. Dardik A, Lin JW, Gordon TA, et al: Results of elective abdominal aortic aneurysm repair in the 1990s: A population-based analysis of 2335 cases. J Vasc Surg 1999;30:985-995
2. Rinckenbach S, Hassani O, Thaveau F, et al: Current outcome of elective open repair for infrarenal abdominal aortic aneurysm. Ann Vasc Surg 2004;18:704-709
3. West CA, Noel AA, Bower TC, et al: Factors affecting outcomes of open surgical repair of pararenal aortic aneurysms: A 10-year experience. J Vasc Surg 2006;43:921-928
4. Gelman S: The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology 1995;82:1026-1057
5. Holzheimer RG, Gross J, Schein M: Pro-and anti-inflammatory cytokine-response in abdominal aortic aneurysm repair: A clinical model of ischemia-reperfusion. Shock 1999;11:305-310
6. Bown MJ, Nicholson ML, Bell P R F, et al: Cytokines and inflammatory pathways in the pathogenesis of multiple organ failure following abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2001;22:485-495
7. Block CA, Manning HL: Prevention of acute renal failure in the critically ill. Am J Respir Crit Care Med 2002;165:320-324
8. Brezis M, Rosen S: Hypoxia of the renal medulla-Its implications for disease. N Engl J Med 1995;332:647-655
9. Conger JD: Interventions in clinical acute renal failure: What are the data? Am J Kidney Dis 1995;26:565-576
10. Shilliday IR, Quinn KJ, Allison M E M: Loop diuretics in the management of acute renal failure: A prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant 1997;12:2592-2596
11. Ho KM, Sheridan DJ: Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 2006;333:420-423
12. Baldwin L, Henderson A, Hickman P: Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 1994;120:744-747
13. Australian and New Zealand Intensive Care Society Clinical Trial Group: Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomized trial. Lancet 2000;356:2139-2143
14. Kellum JA, Decker JM: Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 2001;29:1526-1531
15. Friedrich JO, Adhikari N, Herridge MS, et al: Meta-analysis: Low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005;142:510-524
16. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 1998;339:321-328
17. Marin-Grez M, Fleming JT, Steinhausen M: Atrial natriuretic peptide causes pre-glomerular vasodilation and post-glomerular vasoconstriction in rat kidney. Nature 1986;324:473-476
18. Shaw SG, Weidmann P, Hodler J, et al: Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J Clin Invest 1987;80:1232-1237
19. Nakamoto M, Shapiro JI, Shaniey PF, et al: In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure. J Clin Invest 1987;80:698-705
20. Neumayer HH, Blossei N, Seherr-Thohs U, et al: Amelioration of postischemic acute renal failure in conscious dogs by human atrial natriuretic peptide. Nephrol Dial Transplant 1990;5:32-38
21. Mitaka C, Hirata Y, Habuka K, et al: Atrial natriuretic peptide infusion improves ischemic renal failure after suprarenal abdominal aortic cross-clamping in dogs. Crit Care Med 2003;31:2205-2210
22. Swärd K, Valsson F, Odencrants P, et al: Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial. Crit Care Med 2004;32:1310-1315
23. Bazzi C, Petrini C, Rizza V, et al: Urinary N-acetyl-β- glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002;17:1890-1896
24. Westhuyzen J, Endre ZH, Reece G, et al: Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 2003;18:543-551
25. Hayashi Y, Ohtani M, Sawa Y, et al: Synthetic human α-atrial natriuretic peptide improves the management of postoperative hypertension and renal dysfunction after the repair of abdominal aortic aneurysm. J Cardiovasc Pharmacol 2003;42:636-641
26. Harris PJ, Thomas D, Morgan TO: Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption. Nature 1987;326:697-698
27. Dillingham MA, Anderson RJ: Inhibition of vasopressin action by atrial natriuretic factor. Science 1986;231:1572-1573
28. Sonnenberg H, Honrath U, Chong CK, et al: Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol 1986;250: F963-F966
29. Kiberd BA, Larson TS, Robertson CR, et al: Effect of atrial natriuretic peptide on vasa recta blood flow in the rat. Am J Physiol 1987;252: F1112-F1117
30. Hynninen MS, Niemi TT, Pöyhiä R, et al: N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: A randomized, double-blind, placebo-controlled trial. Anesth Analg 2006;102:1638-1645
31. Sezai A, Hata M, Wakui S, et al: Efficacy of low-dose continuous infusion of human atrial natriuretic peptide (hANP) during cardiac surgery: Possibility of postoperative left ventricular remodeling effect. Circ J 2006;70:1426-1431
32. Allgren RL, Marbury TC, Rahman SN, et al: Anaritide in acute tubular necrosis. N Engl J Med 1997;336:828-834
33. Lewis J, Salem MM, Chertow GM, et al: Atrial natriuretic factor in oliguric acute renal failure. Am J Kidney Dis 2000;36:767-774
34. Mattson DL, Roman S L R J, Cowley AW Jr: Relationship between renal perfusion pressure and blood flow in different regions of the kidney. Am J Physiol Regul Integr Comp Physiol 1993;264: R578-R583
35. Maak T: The broad homeostatic role of natriuretic peptides. Arq Bras Endocrinol Metabo 2006;50:198-207
36. Latini R, Masson S, Anand I, et al: Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: The valsartan heart failure trial (Val-HeFT). Circulation 2002;106:2454-2458
37. Kasama S, Toyama T, Hatori T, et al: Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure. Heart 2006;92:625-630
38. Clerico A, Recchia FA, Passino C, et al: Cardiac endocrine function is an essential component of the homeostatic regulation network: Physiological and clinical implications. Am J Physiol Heart Circ Physiol 2006;290: H17-H29
39. Mann J F E: Cardiovascular risk in patients with mild renal insufficiency: Implications for the use of ACE inhibitors. La Presse Medicale 2007;34:1303-1308
40. Laverman GD, Remuzzi G, Ruggenenti P: ACE inhibition versus angiotensin receptor blockade: Which is better for renal and cardiovascular protection? J Am Soc Nephrol 2004;15: S64-S70
41. MacKinnon M, Shurraw S, Akbari A, et al: Combination therapy with an angiotensin receptor blocker and ACE inhibitor in proteinuric renal disease: A systematic review of the efficacy and safety data. Am J Kidney Dis 2006;48:8-20
42. Bellomo R, Ronco C, Kellum JA, et al: Acute renal failure-Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8: R204-R212